Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1806 2
1807 1
1808 1
1810 1
1860 1
1892 1
1893 1
1946 1
1948 1
1949 1
1952 2
1955 1
1958 1
1960 1
1963 2
1964 3
1965 1
1966 2
1967 2
1969 2
1970 3
1971 4
1972 4
1973 2
1974 6
1975 5
1976 4
1977 8
1978 7
1979 6
1980 7
1981 6
1982 4
1983 5
1984 9
1985 12
1986 12
1987 6
1988 8
1989 16
1990 23
1991 29
1992 25
1993 15
1994 15
1995 15
1996 15
1997 33
1998 38
1999 31
2000 35
2001 35
2002 25
2003 39
2004 32
2005 51
2006 57
2007 71
2008 45
2009 51
2010 62
2011 71
2012 75
2013 64
2014 69
2015 84
2016 64
2017 80
2018 67
2019 76
2020 104
2021 109
2022 107
2023 106
2024 91

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,882 results

Results by year

Filters applied: . Clear all
Page 1
Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of MTAP-Deleted Cancers.
Smith CR, Aranda R, Bobinski TP, Briere DM, Burns AC, Christensen JG, Clarine J, Engstrom LD, Gunn RJ, Ivetac A, Jean-Baptiste R, Ketcham JM, Kobayashi M, Kuehler J, Kulyk S, Lawson JD, Moya K, Olson P, Rahbaek L, Thomas NC, Wang X, Waters LM, Marx MA. Smith CR, et al. Among authors: burns ac. J Med Chem. 2022 Feb 10;65(3):1749-1766. doi: 10.1021/acs.jmedchem.1c01900. Epub 2022 Jan 18. J Med Chem. 2022. PMID: 35041419 Free article.
Frailty in patients on dialysis.
Chan GC, Kalantar-Zadeh K, Ng JK, Tian N, Burns A, Chow KM, Szeto CC, Li PK. Chan GC, et al. Among authors: burns a. Kidney Int. 2024 Jul;106(1):35-49. doi: 10.1016/j.kint.2024.02.026. Epub 2024 May 3. Kidney Int. 2024. PMID: 38705274 Free article. Review.
Donepezil and memantine for moderate-to-severe Alzheimer's disease.
Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Hughes A, Jacoby R, Jones R, Jones R, McKeith I, Macharouthu A, O'Brien J, Passmore P, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown R, Banerjee S, Onions C, Griffin M, Adams J, Gray R, Johnson T, Bentham P, Phillips P. Howard R, et al. Among authors: burns a. N Engl J Med. 2012 Mar 8;366(10):893-903. doi: 10.1056/NEJMoa1106668. N Engl J Med. 2012. PMID: 22397651 Free article. Clinical Trial.
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial.
Banerjee S, High J, Stirling S, Shepstone L, Swart AM, Telling T, Henderson C, Ballard C, Bentham P, Burns A, Farina N, Fox C, Francis P, Howard R, Knapp M, Leroi I, Livingston G, Nilforooshan R, Nurock S, O'Brien J, Price A, Thomas AJ, Tabet N. Banerjee S, et al. Among authors: burns a. Lancet. 2021 Oct 23;398(10310):1487-1497. doi: 10.1016/S0140-6736(21)01210-1. Lancet. 2021. PMID: 34688369 Free PMC article. Clinical Trial.
Maintenance or Discontinuation of Antidepressants in Primary Care.
Lewis G, Marston L, Duffy L, Freemantle N, Gilbody S, Hunter R, Kendrick T, Kessler D, Mangin D, King M, Lanham P, Moore M, Nazareth I, Wiles N, Bacon F, Bird M, Brabyn S, Burns A, Clarke CS, Hunt A, Pervin J, Lewis G. Lewis G, et al. Among authors: burns a. N Engl J Med. 2021 Sep 30;385(14):1257-1267. doi: 10.1056/NEJMoa2106356. N Engl J Med. 2021. PMID: 34587384 Clinical Trial.
The impact of individual Cognitive Stimulation Therapy (iCST) on cognition, quality of life, caregiver health, and family relationships in dementia: A randomised controlled trial.
Orrell M, Yates L, Leung P, Kang S, Hoare Z, Whitaker C, Burns A, Knapp M, Leroi I, Moniz-Cook E, Pearson S, Simpson S, Spector A, Roberts S, Russell I, de Waal H, Woods RT, Orgeta V. Orrell M, et al. Among authors: burns a. PLoS Med. 2017 Mar 28;14(3):e1002269. doi: 10.1371/journal.pmed.1002269. eCollection 2017 Mar. PLoS Med. 2017. PMID: 28350796 Free PMC article. Clinical Trial.
A Moving Target-Vancomycin Therapeutic Monitoring.
Burns AN, Goldman JL. Burns AN, et al. J Pediatric Infect Dis Soc. 2020 Sep 17;9(4):474-478. doi: 10.1093/jpids/piaa078. J Pediatric Infect Dis Soc. 2020. PMID: 32716487 Review.
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.
Banerjee S, Farina N, Henderson C, High J, Stirling S, Shepstone L, Fountain J, Ballard C, Bentham P, Burns A, Fox C, Francis P, Howard R, Knapp M, Leroi I, Livingston G, Nilforooshan R, Nurock S, O'Brien J, Price A, Thomas AJ, Swart AM, Telling T, Tabet N. Banerjee S, et al. Among authors: burns a. Health Technol Assess. 2023 Oct;27(23):1-108. doi: 10.3310/VPDT7105. Health Technol Assess. 2023. PMID: 37929672 Free PMC article. Clinical Trial.
1,882 results